K-877 compound: Clinical Trials

1 trial of K-877 compound, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow K-877 compound: new trials by email Literature Review of K-877 compound trials Research Report on K-877 compound

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
K-877, Placebo - Non-Alcoholic Fatty Liver Disease
Phase 2CompletedKowa Company, Ltd.1182017-12-272021-04-09

Conditions studied

Non-alcoholic Fatty Liver Disease (1)

Sponsors

Kowa Company, Ltd. (1)

Countries

Japan (1)

Top investigators

Ryohei Tanigawa (1)

Results publications

PMID 33392801, PMID 34528723, PMID 41953251